The Clinical Rheumatology Liaison (CRL) represents Crescendo in promoting Crescendo diagnostics along with the concept of Personalized Medicine (PGx) to both academic and community-based rheumatologists, and mid-level practitioners in their territory. The CRL will assure all logistical issues are managed with Health Care Providers (HCP’s).
Myriad Genetics, Inc. (Nasdaq: MYGN) is a leading molecular diagnostic company making a difference in patient’s lives through to discovery and commercialization of transformative molecular diagnostic products that assess a person’s risk of developing disease, improve diagnosis, predict disease progression and guide therapy. We believe in improving the healthcare management of patients by providing physicians and patients with critical information across multiple medical specialties that addresses unmet medical needs. With fiscal year 2015 annual revenue of approximately $700 million and more than 2,000 employees, Myriad is focusing on strategic initiatives, including growing our existing markets, launching new products, and expanding our global presence to take advantage of significant long-term growth opportunities. For more information on Myriad, please visit the Company’s website at: www.myriad.com. Myriad is an equal opportunity employer and as such, affirms in policy and practice to recruit, hire, train and promote, in all job classifications without regard to race, color, religion, gender, age, sexual orientation, gender identity, national origin, disability status or status as a protected veteran.
Reasonable accommodation will be provided for qualified individuals with disabilities and disabled veterans in job application procedures. We believe that diversity lends a regional, national, and global advantage to the clients we serve. Our workforce consists of dynamic individuals, with a range of backgrounds, talents, and skills.